June 25, 2020 / 9:57 PM / 7 days ago

BRIEF-Calmark Says Developing POC-Test To Help Assess Disease Severity For Patients With COVID-19 Patients

June 25 (Reuters) - Calmark Sweden AB:

* CALMARK IS DEVELOPING A POC-TEST TO HELP ASSESS DISEASE SEVERITY FOR PATIENTS WITH COVID-19 PATIENTS

* CALMARK SWEDEN - TO PRIORITIZE DEVELOPMENT OF A DIAGNOSTIC POINT-OF-CARE TEST FOR LACTATE DEHYDROGENASE BIOMARKER AIMED AT ADULT PATIENTS WITH COVID-19

* CALMARK SWEDEN - LACTATE DEHYDROGENASE BIOMARKER HAS BEEN SHOWN IN SEVERAL STUDIES TO BE HELPFUL IN DETERMINING PROGNOSIS IN PATIENTS WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below